New research reveals that while climate anxiety drives many Americans to take action on climate change, those with severe distress may struggle to engage, highlighting the need for mental health support in the fight against environmental threats.
Tennyson On Awakn Life Science’s Application For Phase 3 Trial
[embedded content] In another episode of the The Dales Report Psychedelic Exclusive podcast, we sit down with CEO of Awakn Life Sciences (CBOE: AWKN) Anthony